Resources

Resource types
  • Resource types

  • Applications

  • Resource types

  • Applications

We evaluated 6-base sequencing with duet evoC, which simultaneously profiles 5mC, 5hmC, genetic variants and fragmentomics features from a single cfDNA sample.
The ssDNA duet workflow achieves ultra‑low limits of detection by combining high material recovery with outstanding sensitivity and specificity across genomic and epigenetic features.
Serial plasma dual 5mC/5hmC profiling moved liquid biopsy beyond mutation detection toward transcriptome-like tumor-state and resistance monitoring in mCRPC
We investigated the impact of a duet single stranded ligation workflow on methylation LoD (further details on duet single stranded ligation workflow are provided in poster #121) across duet +modC (which provides 5-base data) and duet evoC (which provides 6-base data, distinguishing between 5mC and 5mC).
We demonstrate the value of integrating genetic and epigenetic information from a single cfDNA assay using the duet evoC technology, which enables simultaneous extraction of complete genetics and complete epigenetics from the same sample.
Here, we assess the contribution of combined fragmentomic and epigenetic features to ctDNA detection in cfDNA from healthy individuals and colorectal cancer (CRC) patients.
This study demonstrates the value of moving beyond legacy epigenetic sequencing technologies that provide a modC readout.
This poster demonstrates compatibility of duet evoC with formalin-damaged DNA including clinical FFPE samples.
Patterns of 5hmC and 5hmC provide insight into tissue-specific gene expression with the ability to better distinguish high and low expressed genes than 5mC or 5modC data.
Using modality XPLR, we reveal variation in 5mC and 5hmC levels across tissues, with a pronounced increase in 5hmC in cerebellum and concomitant decrease in 5mC.
Patterns of 5hmC and 5hmC provide a view on tissue-specific gene expression.
The combination of PARPi (Talazoparib – TAL) and DNMTi (Decitabine – DAC) functions synergistically to inhibit PCa cell lines and patient-derived PTOs.

What are you looking for?